Seeking Alpha

Protalix BioTherapeutics, Inc (PLX)

  • Lowenthal Capital Partners | Send Message 20 May

    Can Protalix BioTherapeutics Deliver? $PLX
      • lexoo | Send Message 12 Feb

        $PLX below $2 is a bargain with run up into Q3 results bound to start soon.
          • Dr.Dre | Send Message 12 Nov 2014

            $PLX is a buy
              • piade | Send Message 11 Nov 2014

                $PLX Protalix announces earnings. ($0.09) EPS vs ($0.06) EST. Misses estimates. $2.5m vs $9.5m. Misses revenue.
                  • Clinically Sound Investor | Send Message 28 Oct 2014

                    Protalix Should Rise On Pivotal Near-Term Clinical Trial Catalyst And Longer-Term Better Insurance... $PLX
                      • BioGroup Team | Send Message 13 Oct 2014

                        Protalix And ZMapp: A Dream Team To Fight Ebola? $PLX
                          • user129 | Send Message 13 Oct 2014

                            What do you guys think of $PLX ?
                              • chipster71 | Send Message 19 Apr 2014

                                Ups and downs on this stock. At this price, it's a good buy. Solid no news quarter all biotech slid ~20% this stock is right there $PLX
                                Reply (5)
                              • View all 5 replies
                                • chipster71 | Send Message 6 Sep 2014
                                  : Yeah I had a chart fail. Double bottom @ $2.35 sitting on a couple shares waiting for catalysts.PRX-112 PRX-102
                                • MichaelJ8 | Send Message 7 Nov 2014
                                  : still going down. Investors do not like this one.
                                  • piade | Send Message 18 Feb 2014

                                    JPMorgan Bullish On Protalix, 8$ target price, upside of 70% $PLX
                                      • Small Pharma Analyst | Send Message 13 Feb 2014

                                        Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology $PLX
                                          Visit Seeking Alpha's
                                          PLX vs. ETF Alternatives
                                          Company Description
                                          Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on itsproprietary ProCellEx protein expression system, or ProCellEx.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States